MedTrace Logo

Acceptability of Zinc-fortified Lipid-based Nutrient Supplements

NCT00944814 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2017-02-23

No results posted yet for this study

Summary

The purpose of the study is to assess the acceptability of the two lipid-based nutrient supplement (LNS) formulations containing no zinc and a high amount of zinc (10 mg zinc / 20 g dose of LNS). The hypothesis is that both products will be equally accepted by children and mothers.

Conditions

  • Malnutrition

Interventions

DIETARY_SUPPLEMENT

LNS with zinc

Lipid-based nutrient supplement (LNS) containing 10 mg zinc/20 g LNS dose

DIETARY_SUPPLEMENT

LNS without zinc

LNS containing no zinc

Sponsors & Collaborators

  • Université Polytechnique de Bobo-Dioulasso

    collaborator OTHER

  • Helen Keller International

    collaborator OTHER

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Kenneth H. Brown, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
9 Months
Max Age
15 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • Burkina Faso

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00944814 on ClinicalTrials.gov